+

WO2011005510A3 - Conjugués peptidiques et leurs utilisations - Google Patents

Conjugués peptidiques et leurs utilisations Download PDF

Info

Publication number
WO2011005510A3
WO2011005510A3 PCT/US2010/039466 US2010039466W WO2011005510A3 WO 2011005510 A3 WO2011005510 A3 WO 2011005510A3 US 2010039466 W US2010039466 W US 2010039466W WO 2011005510 A3 WO2011005510 A3 WO 2011005510A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptide conjugates
biocompatible
affinity
treatment
invention features
Prior art date
Application number
PCT/US2010/039466
Other languages
English (en)
Other versions
WO2011005510A2 (fr
Inventor
James J. Benedict
Original Assignee
Cerapedics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerapedics, Inc. filed Critical Cerapedics, Inc.
Publication of WO2011005510A2 publication Critical patent/WO2011005510A2/fr
Publication of WO2011005510A3 publication Critical patent/WO2011005510A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)

Abstract

L'invention porte sur des compositions comprenant un peptide conjugué à un groupe de liaison ayant une affinité pour un substrat calcifié biocompatible, sur leur utilisation dans des matériaux implantables, et pour le traitement d'états pathologiques.
PCT/US2010/039466 2009-06-22 2010-06-22 Conjugués peptidiques et leurs utilisations WO2011005510A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21916509P 2009-06-22 2009-06-22
US61/219,165 2009-06-22

Publications (2)

Publication Number Publication Date
WO2011005510A2 WO2011005510A2 (fr) 2011-01-13
WO2011005510A3 true WO2011005510A3 (fr) 2011-03-10

Family

ID=43429763

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/039466 WO2011005510A2 (fr) 2009-06-22 2010-06-22 Conjugués peptidiques et leurs utilisations

Country Status (1)

Country Link
WO (1) WO2011005510A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955616B2 (en) 2003-09-23 2011-06-07 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
CN117736134A (zh) * 2012-01-12 2024-03-22 耶鲁大学 通过e3泛素连接酶增强靶蛋白质及其他多肽降解的化合物和方法
WO2014032099A1 (fr) * 2012-08-28 2014-03-06 The Sydney Children's Hospitals Network (Randwick And Westmead) (Incorporating The Royal Alexandra Hospital For Children) Composition et procédé pour la croissance osseuse
GB201311891D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compound
GB201311888D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
US20180228907A1 (en) 2014-04-14 2018-08-16 Arvinas, Inc. Cereblon ligands and bifunctional compounds comprising the same
KR20180097530A (ko) 2015-11-02 2018-08-31 예일 유니버시티 단백질분해 표적화 키메라 화합물(Proteolysis Targeting Chimera compound) 및 그의 제조 및 사용 방법
AU2017301511B2 (en) * 2016-07-25 2023-05-18 Cerapedics, Inc. Peptide-coated calcium phosphate particles
EP3530294A1 (fr) * 2018-02-22 2019-08-28 DSM IP Assets B.V. Procédés de revêtement de particules inorganiques avec un peptide ou une protéine utiles pour améliorer l'activité cellulaire liée à la croissance osseuse
US11235086B2 (en) 2018-02-22 2022-02-01 Cerapedics, Inc. Processes for coating inorganic particles with a peptide or protein useful for improving cellular activity related to bone growth
CN115403654B (zh) * 2022-05-19 2024-06-18 首都医科大学 熊果酰-Asp-Gly-Glu-Ala、其合成、活性和应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
US5958428A (en) * 1989-08-14 1999-09-28 The Regents Of The University Of California Synthetic compounds and compositions with enhanced cell binding
US20020042539A1 (en) * 2000-08-07 2002-04-11 Erik Arstad Bis-phosphonate compounds
US20040019232A1 (en) * 1999-12-03 2004-01-29 Hostetler Karl Y. Phosphonate compounds
WO2006047728A2 (fr) * 2004-10-27 2006-05-04 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Genes bmp et proteines de fusion
EP1932849A1 (fr) * 2006-12-11 2008-06-18 Thermphos Trading GmbH Phosphonates réactifs

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
US5958428A (en) * 1989-08-14 1999-09-28 The Regents Of The University Of California Synthetic compounds and compositions with enhanced cell binding
US20040019232A1 (en) * 1999-12-03 2004-01-29 Hostetler Karl Y. Phosphonate compounds
US20020042539A1 (en) * 2000-08-07 2002-04-11 Erik Arstad Bis-phosphonate compounds
WO2006047728A2 (fr) * 2004-10-27 2006-05-04 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Genes bmp et proteines de fusion
EP1932849A1 (fr) * 2006-12-11 2008-06-18 Thermphos Trading GmbH Phosphonates réactifs

Also Published As

Publication number Publication date
WO2011005510A2 (fr) 2011-01-13

Similar Documents

Publication Publication Date Title
WO2011005510A3 (fr) Conjugués peptidiques et leurs utilisations
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
WO2009073445A3 (fr) Conjugués d'analogues de fumagilline biocompatibles et biodégradables
WO2010042759A3 (fr) Conjugués gaba et procédés d'utilisation de ceux-ci
WO2008070593A3 (fr) Agents se liantà des cibles variables et utilisations de ceux-ci
WO2008079894A3 (fr) Dispositifs médicaux implantables en composites polymère/biocéramique et mélange de polymères/biocéramique
EP2679234A3 (fr) Protéines de liaison qui se lient au FGFR1C humain, au beta-klotho humain et aux deux ensemble
IL212856A (en) Human antibodies against human tissue factor, conjugates and their use
WO2009140015A3 (fr) Modification de facteur ix orientée site
IL208937A0 (en) Cell binding agent cytotoxic drug conjugates, compositions comprising the same and uses thereof
WO2006095029A3 (fr) Conjugues di-polymere-proteine et procedes de preparation de ceux-ci
WO2011101002A3 (fr) Nouvelles compositions d'édulcorants
HK1180237A1 (zh) 抗微生物肽，組合物和使用方法
HK1154795A1 (en) Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
LT2029480T (lt) Karbonato jonais pakeisto hidroksiapatito biologiškai aktyvios nanodalelės, jų gavimo būdas ir jų turinčios kompozicijos
PH12012502150A1 (en) Conjugated blood coagulation factor viii
WO2009124971A3 (fr) Nouvelles compositions et leur utilisation
WO2009114535A3 (fr) Composition de pâte osseuse
MY160510A (en) Polyethylene gycol conjugated blood coagulation factor viia
WO2010121164A3 (fr) Composés de 1,4-benzodiazépinone et leur utilisation dans le traitement du cancer
WO2011044523A3 (fr) Compositions et procédés destinés à traiter l'obésité
WO2009068708A8 (fr) Composition pharmaceutique à libération prolongée de somatostatine ou d'un analogue de celle-ci
MX2010001243A (es) Composicion anti-inflamatoria.
WO2011042501A3 (fr) Récupération musculaire et intestinale
WO2007045977A3 (fr) Preparation d'un materiau osseux

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10797567

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10797567

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载